We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Agfa to Acquire Heartlab for $132 Million

By HospiMedica staff writers
Posted on 26 Apr 2005
Agfa (Mortsel, Belgium) has reached an agreement to acquire all of the shares of Heartlab, Inc. More...
(Westerly, RI, USA), a designer and supplier of image and information networks for cardiology, for U.S.$132.5 million in cash.

This move is designed tostrengthen Agfa's position in healthcare information technology (IT), considerably enhancing its cardiology systems portfolio. Heartlab has contributed to the creation of industry standards and the development of clinical products that improve the management of cardiovascular disease.

Agfa and Heartlab have been working together since December 2003, within a distribution agreement for Agfa's Impax for Cardiology. This joint system allows for the smooth integration of radiology and cardiology, the two most image-intensive departments within hospitals, enabling data to flow more efficiently within the healthcare system and facilitating management of the electronic patient record. This system incorporates the clinical technology and diagnostic tools of both companies' integration and workflow expertise.

"The combination of Heartlab and Agfa will result in substantial growth based on an even more competitive solutions portfolio and our presence and reputation in leading hospitals around the world,” said Ludo Verhoeven, president and CEO of Agfa. "This is an important step in implementing our healthcare strategy and fits well with recent acquisitions.”

Heartlab CEO and co-founder Robert Petrocelli commented, "Joining Agfa offers Heartlab new opportunities in global markets, and thereby strengthens the portfolio and benefits our customers and their patients.” After the acquisition closes, Mr. Petrocelli will manage Agfa's Cardiology business unit.





Related Links:
Agfa
Heartlab

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Critical Care Cart
Avalo
New
12-Lead Electrocardiograph
ASPEL ECG GREY v.07.325
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The novel AI model boosts early detection and treatment of delirium (Photo courtesy of 123RF)

AI Model Boosts Early Delirium Detection for Improving Health Outcomes of Hospitalized Patients

Delirium, a sudden onset of severe confusion, poses serious life-threatening risks and affects up to one-third of patients in hospitals, often going unnoticed. Without intervention, it can lengthen hospital... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.